BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma & Biopharma Manufacturing

Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...

May 08, 2025 | News

Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...

May 06, 2025 | News

Robinson Pharma Expands Production with 10 New Softgel Machines, Boosting Capacity and Speed Across Supplement Formats

Robinson Pharma, a global leader in nutraceutical contract manufacturing, has announced a major expansion of its manufacturing capabilities. As part of thi...

May 02, 2025 | News

Asimov and Cytiva Unite to Fast-Track Complex Biologics Production

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and c...

April 30, 2025 | News

Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion

Amgen (NASDAQ: AMGN), a global leader in biotechnology, announced a $900 million expansion of its state-of-the-art biomanufacturing facility in New A...

April 29, 2025 | News

Australia’s Viral Vector Manufacturing Facility Selects SYSPRO Cloud ERP to Drive Quality and Compliance in Biopharma Manufacturing

Viral Vector Manufacturing Facility Pty Ltd (VVMF) has selected SYSPRO for its Cloud ERP system. VVMF is Australia’s first viral...

April 29, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Thermo Fisher to Invest $2 Billion in U.S. Manufacturing and Innovation Expansion

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next fou...

April 25, 2025 | News

Lotte Biologics Seals First ADC Manufacturing Deal to Launch Full-Scale US Production

Lotte Biologics has announced the signing of its first official contract manufacturing agreement at its newly expanded antibody-drug conjugate (ADC) produc...

April 25, 2025 | News

WuXi Biologics Achieves Asia’s First Commercial PPQ Milestone with 3 x 5,000L Single-Use Bioreactors

- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,0...

April 21, 2025 | News

Thermo Fisher Opens Advanced Therapies Collaboration Center in Carlsbad to Accelerate Cell Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC...

April 18, 2025 | News

Thermo Fisher Launches 5L DynaDrive Single-Use Bioreactor to Accelerate Scalable Bioprocessing

Thermo Fisher Scientific Inc., the world leader in serving science, has introduced the 5L DynaDrive™ Single-Use Bioreactor (S.U.B.), designed to meet...

April 15, 2025 | News

Novartis Commits $23B to U.S. Expansion, Bringing 100% of Key Drug Production Onshore

Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities With new manuf...

April 11, 2025 | News

AGC Biologics Sets New Benchmark in Japan With 5,000 L Single-Use Bioreactors at Yokohama CDMO Site

New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan AGC announced a strategic decision about the large-scale singl...

April 08, 2025 | News

Stay Connected